140 related articles for article (PubMed ID: 2250556)
21. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
22. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
Spanagel R; Almeida OF; Shippenberg TS
Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
[TBL] [Abstract][Full Text] [Related]
23. Cyclic AMP mediates mu and delta, but not kappa opioid analgesia in the spinal cord of the rat.
Wang JF; Ren MF; Xue JC; Han JS
Life Sci; 1993; 52(24):1955-60. PubMed ID: 8099428
[TBL] [Abstract][Full Text] [Related]
24. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
Omote K; Kitahata LM; Nakatani K; Collins JG
Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
[TBL] [Abstract][Full Text] [Related]
25. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy.
Chabot-Doré AJ; Millecamps M; Stone LS
J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246
[TBL] [Abstract][Full Text] [Related]
26. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
27. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Chung KM; Kim YH; Huh SO; Song DK
Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
[TBL] [Abstract][Full Text] [Related]
28. Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat.
Drasner K; Fields HL
Pain; 1988 Mar; 32(3):309-312. PubMed ID: 3362566
[TBL] [Abstract][Full Text] [Related]
29. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
30. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
31. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
32. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity.
Horan P; Tallarida RJ; Haaseth RC; Matsunaga TO; Hruby VJ; Porreca F
Life Sci; 1992; 50(20):1535-41. PubMed ID: 1315897
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
35. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
DeLander GE; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cocaine-induced antinociception by opioid-receptor agonists.
Waddell AB; Holtzman SG
Pharmacol Biochem Behav; 1999 Feb; 62(2):247-53. PubMed ID: 9972691
[TBL] [Abstract][Full Text] [Related]
37. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
38. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.
Naguib M; Yaksh TL
Anesthesiology; 1994 Jun; 80(6):1338-48. PubMed ID: 8010479
[TBL] [Abstract][Full Text] [Related]
40. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice.
Suh HH; Tseng LF
Life Sci; 1990; 46(11):759-65. PubMed ID: 2157119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
